跳至主要内容
临床试验/NCT03300206
NCT03300206已完成不适用

A Prospective, Block Stratified Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

Hologic, Inc.7 个研究点 分布在 1 个国家目标入组 525 人开始时间: 2017年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Hologic, Inc.
入组人数
525
试验地点
7
主要终点
Difference in Procedural Time in Minutes

研究概览

简要总结

The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current standard-of-care breast biopsy procedures

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female aged 18 years of age or older
  • Subject has at least one breast imaging finding requiring biopsy for which images are available
  • Subject is able to understand, read and sign the trial specific informed consent form after the nature of the trial has been fully explained to her

排除标准

  • Patients who, based on the physician's judgment, may be at increased risk or develop complications associated with core removal or biopsy.
  • Patients receiving anticoagulant therapy or may have bleeding disorders which may put the patient at increased risk of procedural complications based upon physicians judgment.

结局指标

主要结局

Difference in Procedural Time in Minutes

时间窗: Average Time- Procedure (1 Lesion per subject): Total Time elapsed from when the subject enters the procedure room until they have left the procedure room, an average of 43 minutes.

The primary endpoint of this trial is the measured difference in procedure time between biopsies performed with the Brevera biopsy system and those performed with the standard-of-care biopsy systems at each clinical site. Additionally, feedback from the perspective of the participant radiologists, technologists, and subjects using the systems was reported.

次要结局

  • Post-biopsy Complication Rates(The time of consent until the subject procedure was completed, an average of 1 day)
  • Number of Samples Collected Per Lesion(Samples collected from day of Breast Biopsy Procedure Only)
  • Percentage of Procedures With Overall Positive Opinion From Radiologists, Technologists and Patients(Through study completion, enrollment expected to take up to 6-10 months at each participant site. Data collected from day of Breast Biopsy Procedure Only)

研究者

发起方
Hologic, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验